Earnings summaries and quarterly performance for Cardlytics.
Executive leadership at Cardlytics.
Board of directors at Cardlytics.
Research analysts who have asked questions during Cardlytics earnings calls.
Cal Bartyzal
Craig-Hallum Capital Group LLC
3 questions for CDLX
Jacob Stephan
Lake Street Capital Markets, LLC
3 questions for CDLX
Lucas John Horton
Northland Capital Markets
3 questions for CDLX
Robert Coolbrith
Evercore ISI
2 questions for CDLX
Arthur Chu
Bank of America
1 question for CDLX
Jason Kreyer
Craig-Hallum Capital Group LLC
1 question for CDLX
Kyle Peterson
Needham & Company
1 question for CDLX
Luke Horton
Northland Capital Markets
1 question for CDLX
Robert Culbreth
B. Riley Securities
1 question for CDLX
Robert Kobrik
Evercore ISI
1 question for CDLX
Recent press releases and 8-K filings for CDLX.
- Cardlytics reported Q3 2025 billings of $89.2 million, a 20.3% decrease year-over-year, and revenue of $52.0 million, down 22.4%. Despite top-line weakness, adjusted EBITDA was positive $3.2 million, an increase of $5.0 million from the prior year.
- The company experienced headwinds from its largest FI partner blocking advertiser content, which impacted billings, but mitigated a significant portion by shifting volume to other partners and expanding its network.
- Cardlytics implemented a 30% workforce reduction in Q3, contributing to $26 million in annualized cash savings, following earlier reductions totaling $50 million this year.
- For Q4 2025, the company expects billings between $86 million and $96 million and adjusted EBITDA between $0.9 million and $7.9 million, aiming for positive adjusted EBITDA for both the quarter and full year.
- Strategic initiatives include signing three new CRP partners, including OpenTable, with two expected to launch in Q4, and continued 22% revenue growth in the U.K..
- Cardlytics reported Q3 2025 revenue of $52.0 million, a 22% decrease year-over-year, and a Net Loss of $(72.7) million, or $(1.36) per diluted share.
- Adjusted EBITDA for Q3 2025 was $3.2 million, an improvement compared to $(1.8) million in the third quarter of 2024.
- The company's monthly qualified users (MQUs) increased by 21% year-over-year to 230.3 million in Q3 2025.
- For Q4 2025, Cardlytics anticipates Billings between $86.0 million and $96.0 million and Revenue between $51.1 million and $59.1 million.
Quarterly earnings call transcripts for Cardlytics.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more